Ltd. “Pharmaceutical, Biomedical and Medical Technology Competence Center” covers two scientific areas:

–Pharmacy, originator, and generic medicines
–Medicines of natural substances, food supplements, functional cosmetics.

European Regional Development Fund Operational Program “Growth and Employment” 1.2.1. specific aid objective “Increase private sector investment in R&D” 1.2.1.1. activity “Support for the development of new products and technologies within the competence centers” project No. 1.2.1.1/18/A/005 “Pharmaceutical, Biomedical and Medical Technology Competence Center”, JSC Olainfarm implements three research projects:

–“Pre-clinical and clinical trials for medical products”, the planned implementation period of the project is from March 1, 2019, to June 30, 2022.
–“Studies on Active Pharmaceutical Ingredients”, the planned project implementation period is from October 1, 2020, to June 30, 2022.|
–“Clinical trials for medical products”, the planned implementation period of the project is from January 4, 2021, to June 30, 2022.